FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2000498293> ?p ?o ?g. }

• W2000498293 endingPage "860" @default.
• W2000498293 startingPage "853" @default.
• W2000498293 abstract "BACKGROUND: Bone mineral density has been reduced in patients with asthma taking inhaled corticosteroids in some cross sectional studies and this could be important if treatment is continued for several decades. The possibility of confounding by age, menopausal status, physical activity and, especially, past oral steroid use has not been excluded in most studies. The present study was designed to assess the magnitude of any reduction in bone mineral density in relation to inhaled steroid use after adjusting for these factors. METHODS: Bone mineral density (BMD), vertebral fractures, and markers of bone metabolism (serum osteocalcin, procollagen peptide I, bone-specific alkaline phosphatase, and urinary deoxypyridinoline cross links) were measured in 81 patients with asthma age 20-40 years; 34 patients (19 men) who had never had inhaled or systemic steroids and 47 (19 men) who had taken inhaled steroids for at least five years with limited exposure to systemic steroids in the past. Data relating to past medication use, physical activity, smoking, and other confounding factors were collected by questionnaire. The relation between inhaled steroid dose and duration and BMD was assessed by linear regression analysis, accounting for potential confounders including weight, exercise, and oral steroid use. RESULTS: The 47 patients taking an inhaled steroid had a mean current dose of 620 micrograms/day (range 100-3000 micrograms), a mean duration of use of 7.8 years, and had had a mean of 0.85 courses of prednisolone in the past. There was no significant difference in mean BMD values between those who were and those who were not on inhaled steroids in men or women. However, on multivariate analysis, cumulative inhaled steroid dose was associated with a reduction in posterior-anterior (P-A) and lateral lumbar spine bone mineral density in women, equivalent to a 0.11 standard deviation reduction in bone density per 1000 micrograms/day inhaled steroid per year after adjustment for potential confounding factors (95% CI for P-A spine 0.01 to 0.22; for lateral spine 0.02 to 0.21). Previous oral steroid use was not an important confounding factor in these patients. Inhaled steroid use was not related to BMD at the wrist or hip in women or at any skeletal site in men. Women taking an inhaled steroid had lower levels of serum osteocalcin than those not taking them, although this was not dose related. Inhaled steroid use was not associated with differences in other markers of bone metabolism in men or women or with the presence of vertebral fractures. CONCLUSIONS: Although an effect of confounding factors cannot be excluded entirely in a cross sectional study, our findings are in keeping with an effect of inhaled steroid therapy in reducing bone density in the spine in women and provide an estimate of the magnitude of this effect." @default.
• W2000498293 created "2016-06-24" @default.
• W2000498293 creator A5005210865 @default.
• W2000498293 creator A5016158210 @default.
• W2000498293 creator A5020796436 @default.
• W2000498293 creator A5063609461 @default.
• W2000498293 creator A5072287115 @default.
• W2000498293 creator A5087299666 @default.
• W2000498293 date "1997-10-01" @default.
• W2000498293 modified "2023-10-18" @default.
• W2000498293 title "Cross sectional investigation of the effects of inhaled corticosteroids on bone density and bone metabolism in patients with asthma." @default.
• W2000498293 cites W1967827648 @default.
• W2000498293 cites W1979035516 @default.
• W2000498293 cites W1982314879 @default.
• W2000498293 cites W1987809980 @default.
• W2000498293 cites W1990808273 @default.
• W2000498293 cites W1993401012 @default.
• W2000498293 cites W1995346107 @default.
• W2000498293 cites W1999868679 @default.
• W2000498293 cites W2001441002 @default.
• W2000498293 cites W2005369718 @default.
• W2000498293 cites W2018076401 @default.
• W2000498293 cites W2021323052 @default.
• W2000498293 cites W2022082810 @default.
• W2000498293 cites W2030639081 @default.
• W2000498293 cites W2034005860 @default.
• W2000498293 cites W2035862447 @default.
• W2000498293 cites W2040050038 @default.
• W2000498293 cites W2042457399 @default.
• W2000498293 cites W2045358685 @default.
• W2000498293 cites W2052236120 @default.
• W2000498293 cites W2059128728 @default.
• W2000498293 cites W2076089682 @default.
• W2000498293 cites W2076722427 @default.
• W2000498293 cites W2080530247 @default.
• W2000498293 cites W2083311965 @default.
• W2000498293 cites W2094903912 @default.
• W2000498293 cites W2097821130 @default.
• W2000498293 cites W2099459969 @default.
• W2000498293 cites W2110980418 @default.
• W2000498293 cites W2111753128 @default.
• W2000498293 cites W2112102331 @default.
• W2000498293 cites W2146664122 @default.
• W2000498293 cites W2158353324 @default.
• W2000498293 cites W2242810181 @default.
• W2000498293 cites W2338308982 @default.
• W2000498293 cites W2425633592 @default.
• W2000498293 doi "https://doi.org/10.1136/thx.52.10.853" @default.
• W2000498293 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/1758420" @default.
• W2000498293 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9404371" @default.
• W2000498293 hasPublicationYear "1997" @default.
• W2000498293 type Work @default.
• W2000498293 sameAs 2000498293 @default.
• W2000498293 citedByCount "62" @default.
• W2000498293 countsByYear W20004982932013 @default.
• W2000498293 countsByYear W20004982932015 @default.
• W2000498293 countsByYear W20004982932017 @default.
• W2000498293 countsByYear W20004982932021 @default.
• W2000498293 crossrefType "journal-article" @default.
• W2000498293 hasAuthorship W2000498293A5005210865 @default.
• W2000498293 hasAuthorship W2000498293A5016158210 @default.
• W2000498293 hasAuthorship W2000498293A5020796436 @default.
• W2000498293 hasAuthorship W2000498293A5063609461 @default.
• W2000498293 hasAuthorship W2000498293A5072287115 @default.
• W2000498293 hasAuthorship W2000498293A5087299666 @default.
• W2000498293 hasBestOaLocation W20004982932 @default.
• W2000498293 hasConcept C126322002 @default.
• W2000498293 hasConcept C131075544 @default.
• W2000498293 hasConcept C134018914 @default.
• W2000498293 hasConcept C142052008 @default.
• W2000498293 hasConcept C142724271 @default.
• W2000498293 hasConcept C160160445 @default.
• W2000498293 hasConcept C170033053 @default.
• W2000498293 hasConcept C181199279 @default.
• W2000498293 hasConcept C185592680 @default.
• W2000498293 hasConcept C2776042228 @default.
• W2000498293 hasConcept C2776541429 @default.
• W2000498293 hasConcept C2776886416 @default.
• W2000498293 hasConcept C2779329777 @default.
• W2000498293 hasConcept C2780787237 @default.
• W2000498293 hasConcept C42407357 @default.
• W2000498293 hasConcept C55493867 @default.
• W2000498293 hasConcept C71924100 @default.
• W2000498293 hasConcept C77350462 @default.
• W2000498293 hasConceptScore W2000498293C126322002 @default.
• W2000498293 hasConceptScore W2000498293C131075544 @default.
• W2000498293 hasConceptScore W2000498293C134018914 @default.
• W2000498293 hasConceptScore W2000498293C142052008 @default.
• W2000498293 hasConceptScore W2000498293C142724271 @default.
• W2000498293 hasConceptScore W2000498293C160160445 @default.
• W2000498293 hasConceptScore W2000498293C170033053 @default.
• W2000498293 hasConceptScore W2000498293C181199279 @default.
• W2000498293 hasConceptScore W2000498293C185592680 @default.
• W2000498293 hasConceptScore W2000498293C2776042228 @default.
• W2000498293 hasConceptScore W2000498293C2776541429 @default.
• W2000498293 hasConceptScore W2000498293C2776886416 @default.
• W2000498293 hasConceptScore W2000498293C2779329777 @default.
• W2000498293 hasConceptScore W2000498293C2780787237 @default.

• next